CORD-19:867ebb2be2d466bcb35e5a7319708eaff39c4799 / 37051-37284 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T304","span":{"begin":0,"end":233},"obj":"Sentence"}],"text":"resistant Gram positive pathogens, such as S. pneumoniae, Staphylococcus aureus, and Enterococcus, will be used to assess in vitro resistance development to nemonoxacin, in comparison to ciprofloxacin, levofloxacin, and moxifloxacin."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T304","span":{"begin":0,"end":233},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"resistant Gram positive pathogens, such as S. pneumoniae, Staphylococcus aureus, and Enterococcus, will be used to assess in vitro resistance development to nemonoxacin, in comparison to ciprofloxacin, levofloxacin, and moxifloxacin."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T34","span":{"begin":46,"end":56},"obj":"Phenotype"}],"attributes":[{"id":"A34","pred":"hp_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"resistant Gram positive pathogens, such as S. pneumoniae, Staphylococcus aureus, and Enterococcus, will be used to assess in vitro resistance development to nemonoxacin, in comparison to ciprofloxacin, levofloxacin, and moxifloxacin."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T98","span":{"begin":46,"end":56},"obj":"Disease"},{"id":"T6087","span":{"begin":46,"end":56},"obj":"Disease"}],"attributes":[{"id":"A98","pred":"mondo_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A43921","pred":"mondo_id","subj":"T6087","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"}],"text":"resistant Gram positive pathogens, such as S. pneumoniae, Staphylococcus aureus, and Enterococcus, will be used to assess in vitro resistance development to nemonoxacin, in comparison to ciprofloxacin, levofloxacin, and moxifloxacin."}